BMY logo

Bristol-Myers Squibb Company (BMY) Selling, general & administrative expenses

annual SGA:

$0.00-$7.77B(-100.00%)
December 31, 2024

Summary

  • As of today (August 26, 2025), BMY annual SGA is $0.00, with the most recent change of -$7.77 billion (-100.00%) on December 31, 2024.
  • During the last 3 years, BMY annual SGA has fallen by -$7.69 billion (-100.00%).
  • BMY annual SGA is now -100.00% below its all-time high of $7.81 billion, reached on December 31, 2022.

Performance

BMY SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

quarterly SGA:

$0.00-$1.58B(-100.00%)
June 30, 2025

Summary

  • As of today (August 26, 2025), BMY quarterly SGA is $0.00, with the most recent change of -$1.58 billion (-100.00%) on June 30, 2025.
  • Over the past year, BMY quarterly SGA has dropped by -$1.93 billion (-100.00%).
  • BMY quarterly SGA is now -100.00% below its all-time high of $2.72 billion, reached on December 31, 2020.

Performance

BMY quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

TTM SGA:

$63.27B+$51.00M(+0.08%)
June 30, 2025

Summary

  • As of today (August 26, 2025), BMY TTM SGA is $63.27 billion, with the most recent change of +$51.00 million (+0.08%) on June 30, 2025.
  • Over the past year, BMY TTM SGA has increased by +$54.90 billion (+655.81%).
  • BMY TTM SGA is now -55.45% below its all-time high of $142.01 billion.

Performance

BMY TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

BMY Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%+655.8%
3 y3 years-100.0%-100.0%+715.3%
5 y5 years-100.0%-100.0%+950.5%

BMY Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%at low-43.0%+0.8%
5 y5-year-100.0%at low-100.0%at low-53.2%+0.8%
alltimeall time-100.0%at low-100.0%at low-55.5%+1277.2%

BMY Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$3.57B(-35.1%)
Mar 2025
-
$1.58B(>+9900.0%)
$5.50B(-12.5%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$6.28B(-24.8%)
Sep 2024
-
$1.98B(+2.9%)
$8.35B(-0.2%)
Jun 2024
-
$1.93B(-18.5%)
$8.37B(-0.1%)
Mar 2024
-
$2.37B(+14.2%)
$8.38B(+7.8%)
Dec 2023
$7.77B(-0.5%)
$2.07B(+3.5%)
$7.77B(-2.4%)
Sep 2023
-
$2.00B(+3.6%)
$7.96B(+0.9%)
Jun 2023
-
$1.93B(+9.8%)
$7.89B(+1.9%)
Mar 2023
-
$1.76B(-22.2%)
$7.75B(-0.9%)
Dec 2022
$7.81B(+1.6%)
$2.27B(+17.4%)
$7.81B(-1.1%)
Sep 2022
-
$1.93B(+8.0%)
$7.90B(+1.8%)
Jun 2022
-
$1.79B(-2.4%)
$7.76B(-1.2%)
Mar 2022
-
$1.83B(-22.2%)
$7.86B(+2.1%)
Dec 2021
$7.69B(+0.4%)
$2.35B(+31.7%)
$7.69B(-4.6%)
Sep 2021
-
$1.79B(-5.0%)
$8.06B(+1.0%)
Jun 2021
-
$1.88B(+13.0%)
$7.97B(+3.3%)
Mar 2021
-
$1.67B(-38.8%)
$7.72B(+0.8%)
Dec 2020
$7.66B(+57.3%)
$2.72B(+59.5%)
$7.66B(+14.8%)
Sep 2020
-
$1.71B(+4.8%)
$6.67B(+10.8%)
Jun 2020
-
$1.63B(+1.4%)
$6.02B(+10.1%)
Mar 2020
-
$1.61B(-7.4%)
$5.47B(+12.3%)
Dec 2019
$4.87B(+7.0%)
$1.73B(+64.4%)
$4.87B(+8.9%)
Sep 2019
-
$1.05B(-2.0%)
$4.47B(-1.1%)
Jun 2019
-
$1.08B(+7.0%)
$4.52B(-1.2%)
Mar 2019
-
$1.01B(-24.7%)
$4.58B(+0.6%)
Dec 2018
$4.55B(-4.2%)
$1.34B(+21.0%)
$4.55B(+0.4%)
Sep 2018
-
$1.10B(-2.4%)
$4.53B(-0.9%)
Jun 2018
-
$1.13B(+15.4%)
$4.57B(-0.8%)
Mar 2018
-
$980.00M(-25.5%)
$4.61B(-2.2%)
Dec 2017
$4.75B(-3.3%)
$1.32B(+14.7%)
$4.71B(-3.0%)
Sep 2017
-
$1.15B(-1.7%)
$4.86B(+0.1%)
Jun 2017
-
$1.17B(+7.6%)
$4.86B(-1.4%)
Mar 2017
-
$1.08B(-25.7%)
$4.93B(+0.3%)
Dec 2016
$4.91B(+1.4%)
$1.46B(+27.7%)
$4.91B(-0.8%)
Sep 2016
-
$1.14B(-7.6%)
$4.95B(-0.6%)
Jun 2016
-
$1.24B(+15.9%)
$4.98B(+2.1%)
Mar 2016
-
$1.07B(-28.8%)
$4.88B(+0.8%)
Dec 2015
$4.84B(+0.4%)
$1.50B(+27.6%)
$4.84B(+2.9%)
Sep 2015
-
$1.18B(+3.6%)
$4.70B(-0.5%)
Jun 2015
-
$1.14B(+10.3%)
$4.73B(-0.1%)
Mar 2015
-
$1.03B(-24.6%)
$4.73B(-1.9%)
Dec 2014
$4.82B(-2.4%)
$1.36B(+13.7%)
$4.82B(+0.9%)
Sep 2014
-
$1.20B(+5.4%)
$4.78B(+0.5%)
Jun 2014
-
$1.14B(+1.6%)
$4.75B(-2.5%)
Mar 2014
-
$1.12B(-15.3%)
$4.88B(-1.3%)
Dec 2013
$4.94B(-1.6%)
$1.32B(+12.6%)
$4.94B(-0.7%)
Sep 2013
-
$1.17B(-6.8%)
$4.97B(-1.3%)
Jun 2013
-
$1.26B(+6.5%)
$5.04B(+0.6%)
Mar 2013
-
$1.18B(-12.7%)
$5.00B(-0.3%)
Dec 2012
$5.02B(-2.8%)
$1.35B(+9.5%)
$5.02B(-2.8%)
Sep 2012
-
$1.24B(+0.8%)
$5.16B(+0.3%)
Jun 2012
-
$1.23B(+2.7%)
$5.15B(-1.2%)
Mar 2012
-
$1.20B(-20.3%)
$5.21B(+1.0%)
Dec 2011
$5.16B(+10.7%)
$1.50B(+22.6%)
$5.16B(+4.7%)
Sep 2011
-
$1.22B(-5.3%)
$4.93B(+2.1%)
Jun 2011
-
$1.29B(+13.2%)
$4.83B(+2.9%)
Mar 2011
-
$1.14B(-10.1%)
$4.69B(+0.6%)
Dec 2010
$4.66B(-8.2%)
$1.27B(+13.2%)
$4.66B(+12.9%)
Sep 2010
-
$1.12B(-2.9%)
$4.13B(-7.9%)
Jun 2010
-
$1.16B(+4.0%)
$4.49B(-6.7%)
Mar 2010
-
$1.11B(+50.5%)
$4.81B(-5.4%)
Dec 2009
$5.08B(-19.9%)
$739.00M(-50.0%)
$5.08B(-16.4%)
Sep 2009
-
$1.48B(+0.1%)
$6.08B(-1.5%)
Jun 2009
-
$1.48B(+6.4%)
$6.17B(-1.7%)
Mar 2009
-
$1.39B(-20.0%)
$6.28B(-2.6%)
Dec 2008
$6.34B(+0.3%)
$1.73B(+10.4%)
$6.44B(-0.3%)
Sep 2008
-
$1.57B(-0.9%)
$6.46B(+0.1%)
Jun 2008
-
$1.58B(+2.1%)
$6.45B(+0.1%)
Mar 2008
-
$1.55B(-11.3%)
$6.45B(+2.0%)
Dec 2007
$6.32B(+31.6%)
$1.75B(+11.9%)
$6.32B(+0.3%)
Sep 2007
-
$1.56B(-0.8%)
$6.30B(+1.4%)
Jun 2007
-
$1.58B(+10.5%)
$6.21B(+0.7%)
Mar 2007
-
$1.43B(-17.5%)
$6.16B(-1.7%)
Dec 2006
$4.80B
$1.73B(+17.2%)
$6.27B(-1.3%)
Sep 2006
-
$1.48B(-3.8%)
$6.35B(-2.5%)
DateAnnualQuarterlyTTM
Jun 2006
-
$1.53B(0.0%)
$6.51B(-1.5%)
Mar 2006
-
$1.53B(-15.4%)
$6.61B(+0.5%)
Dec 2005
$6.58B(+31.2%)
$1.81B(+10.9%)
$6.58B(-0.0%)
Sep 2005
-
$1.64B(+0.1%)
$6.58B(+1.6%)
Jun 2005
-
$1.63B(+8.8%)
$6.48B(+1.2%)
Mar 2005
-
$1.50B(-17.3%)
$6.41B(-0.8%)
Dec 2004
$5.02B(-17.4%)
$1.81B(+18.3%)
$6.46B(+1.0%)
Sep 2004
-
$1.53B(-1.5%)
$6.39B(+0.6%)
Jun 2004
-
$1.56B(+0.5%)
$6.35B(+1.3%)
Mar 2004
-
$1.55B(-11.6%)
$6.27B(+2.5%)
Dec 2003
$6.08B(+15.3%)
$1.75B(+17.4%)
$6.12B(+40.2%)
Sep 2003
-
$1.49B(+1.2%)
$4.37B(+5.3%)
Jun 2003
-
$1.48B(+5.7%)
$4.14B(-1.4%)
Mar 2003
-
$1.40B(>+9900.0%)
$4.20B(+5.3%)
Dec 2002
$5.27B(+1.4%)
$0.00(-100.0%)
$3.99B(0.0%)
Sep 2002
-
$1.27B(-17.0%)
$3.99B(-20.0%)
Jun 2002
-
$1.53B(+29.5%)
$4.99B(+3.5%)
Mar 2002
-
$1.18B(>+9900.0%)
$4.82B(-0.6%)
Dec 2001
$5.19B(+34.5%)
$0.00(-100.0%)
$4.85B(0.0%)
Sep 2001
-
$2.27B(+66.2%)
$4.85B(+88.1%)
Jun 2001
-
$1.37B(+12.8%)
$2.58B(+112.8%)
Mar 2001
-
$1.21B(>+9900.0%)
$1.21B(>+9900.0%)
Dec 2000
$3.86B(-44.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$6.99B(+3.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1998
$6.73B(+4.9%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1998
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 1998
-
$0.00(0.0%)
$1.50B(-51.8%)
Mar 1998
-
$0.00(0.0%)
$3.11B(-32.6%)
Dec 1997
$6.41B(+9.2%)
$0.00(-100.0%)
$4.62B(0.0%)
Sep 1997
-
$1.50B(-7.1%)
$4.62B(+3.4%)
Jun 1997
-
$1.61B(+7.0%)
$4.47B(+2.6%)
Mar 1997
-
$1.51B(>+9900.0%)
$4.36B(+2.3%)
Dec 1996
$5.87B(+10.4%)
$0.00(-100.0%)
$4.26B(-26.1%)
Sep 1996
-
$1.35B(-10.4%)
$5.76B(+2.0%)
Jun 1996
-
$1.50B(+6.5%)
$5.64B(+2.2%)
Mar 1996
-
$1.41B(-6.1%)
$5.52B(+3.9%)
Dec 1995
$5.32B(+17.3%)
$1.50B(+21.8%)
$5.32B(+3.5%)
Sep 1995
-
$1.23B(-10.7%)
$5.14B(+4.2%)
Jun 1995
-
$1.38B(+14.8%)
$4.93B(+4.1%)
Mar 1995
-
$1.20B(-9.1%)
$4.73B(+4.5%)
Dec 1994
$4.53B(+4.1%)
$1.32B(+29.1%)
$4.53B(-14.4%)
Sep 1994
-
$1.02B(-13.6%)
$5.30B(-4.5%)
Jun 1994
-
$1.19B(+18.5%)
$5.55B(-3.4%)
Mar 1994
-
$1.00B(-52.1%)
$5.74B(-3.9%)
Dec 1993
$4.35B(+4.7%)
$2.09B(+63.6%)
$5.98B(+0.1%)
Sep 1993
-
$1.28B(-7.6%)
$5.97B(-3.2%)
Jun 1993
-
$1.38B(+11.7%)
$6.17B(-1.3%)
Mar 1993
-
$1.24B(-40.6%)
$6.25B(-1.4%)
Dec 1992
$4.16B(-23.9%)
$2.08B(+41.3%)
$6.34B(+8.4%)
Sep 1992
-
$1.47B(+0.6%)
$5.85B(+3.8%)
Jun 1992
-
$1.46B(+10.5%)
$5.64B(+2.5%)
Mar 1992
-
$1.32B(-16.7%)
$5.50B(+0.7%)
Dec 1991
$5.46B(+31.4%)
$1.59B(+26.2%)
$5.46B(+1.6%)
Sep 1991
-
$1.26B(-4.9%)
$5.38B(+1.4%)
Jun 1991
-
$1.32B(+2.9%)
$5.30B(+2.8%)
Mar 1991
-
$1.29B(-14.5%)
$5.16B(+2.5%)
Dec 1990
$4.16B(-9.6%)
$1.51B(+27.0%)
$5.04B(+42.7%)
Sep 1990
-
$1.19B(+0.3%)
$3.53B(+50.6%)
Jun 1990
-
$1.18B(+1.6%)
$2.35B(+101.6%)
Mar 1990
-
$1.16B
$1.16B
Dec 1989
$4.59B(+54.2%)
-
-
Dec 1988
$2.98B(>+9900.0%)
-
-
Dec 1987
$0.00(0.0%)
-
-
Dec 1986
$0.00(0.0%)
-
-
Dec 1985
$0.00(0.0%)
-
-
Dec 1984
$0.00(0.0%)
-
-
Dec 1983
$0.00(0.0%)
-
-
Dec 1982
$0.00(0.0%)
-
-
Dec 1981
$0.00(0.0%)
-
-
Dec 1980
$0.00
-
-

FAQ

  • What is Bristol-Myers Squibb Company annual SGA?
  • What is the all time high annual SGA for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company annual SGA year-on-year change?
  • What is Bristol-Myers Squibb Company quarterly SGA?
  • What is the all time high quarterly SGA for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company quarterly SGA year-on-year change?
  • What is Bristol-Myers Squibb Company TTM SGA?
  • What is the all time high TTM SGA for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company TTM SGA year-on-year change?

What is Bristol-Myers Squibb Company annual SGA?

The current annual SGA of BMY is $0.00

What is the all time high annual SGA for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high annual SGA is $7.81B

What is Bristol-Myers Squibb Company annual SGA year-on-year change?

Over the past year, BMY annual SGA has changed by -$7.77B (-100.00%)

What is Bristol-Myers Squibb Company quarterly SGA?

The current quarterly SGA of BMY is $0.00

What is the all time high quarterly SGA for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high quarterly SGA is $2.72B

What is Bristol-Myers Squibb Company quarterly SGA year-on-year change?

Over the past year, BMY quarterly SGA has changed by -$1.93B (-100.00%)

What is Bristol-Myers Squibb Company TTM SGA?

The current TTM SGA of BMY is $63.27B

What is the all time high TTM SGA for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high TTM SGA is $142.01B

What is Bristol-Myers Squibb Company TTM SGA year-on-year change?

Over the past year, BMY TTM SGA has changed by +$54.90B (+655.81%)
On this page